Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01948271 · ClinicalTrials.gov registry record · Phase 1
Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis
A Phase 1 study, sponsored by Tufts Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT01948271 is a Phase 1 study that was terminated before completion, run by Tufts Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT01948271, a Phase 1 study, was terminated before completion, sponsored by Tufts Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this research study is to better understand whether trichuris suis ova (TSO) ingested orally may be safe and effective in the treatment of psoriasis.
Interventions
- DRUG Trichuris Suis Ova
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01948271
The ClinicalTrials.gov registry entry for NCT01948271 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trichuris Suis Ova is the first listed.
NCT01948271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01948271 about?
NCT01948271 is a clinical study titled "Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis". The purpose of this research study is to better understand whether trichuris suis ova (TSO) ingested orally may be safe and effective in the treatment of psoriasis.
What is the current status of trial NCT01948271?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2013-07. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01948271?
The interventions under investigation include: Trichuris Suis Ova (DRUG).
Who is sponsoring clinical trial NCT01948271?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.